Supported Features
The following is a list of supported features
We iterate fast. If there's a feature your team needs sooner, reach out to your Customer Success Manager or contact us at support@mithrl.com
Feature Overview
Exploratory Data Analysis (EDA)
✅ Supported
Bulk, scRNA-seq, Proteomics, DRUG-seq, Code-Omics
Supporting QC, normalization, ample filtering, and outlier detection.
Differential Expression Analysis (DEA)
✅ Supported
Bulk, scRNA-seq, Proteomics, DRUG-seq, Code-Omics
Supports Bulk RNA-seq (DESeq2, Limma, pseudobulk counts. scRNA-seq (cell type specific Wilcoxon rank-sum. Proteomics, DrugSeq, CodeOmics
Functional Enrichment Analysis (FEA)
✅ Supported
Bulk, scRNA-seq, Proteomics, DRUG-seq, Code-Omics
Performs Gene Set Enrichment Analysis (GSEA) and Over-Representation Analysis (ORA) to identify enriched biological processes, molecular functions, and cellular components from your expression or abundance data. Outputs enrichment bar charts, pathway and gene set overlays and gene-set relationship tables. KEGG-based analysis with overlays.
Target Discovery
✅ Supported
Bulk, scRNA-seq, Proteomics, DRUG-seq, Code-Omics
Supporting raw fastq or expression matrix files (h5ad, csv, etc) as input to infer PPI networks and predicted targets. Integrates expression networks and literature.
Protein-Protein Interaction
✅ Supported
Bulk, scRNA-seq, Proteomics, DRUG-seq, Code-Omics
Visualize gene interaction networks and identify hubs or regulators based on expression data.
Clustering Analysis
✅ Supported
Bulk, scRNA-seq, Proteomics, DRUG-seq, Code-Omics
Group similar samples or cells by expression profile. Leiden/Louvain supported
Dimensionality Reduction
✅ Supported
Bulk, scRNA-seq, Proteomics, DRUG-seq, Code-Omics
Visualize structure using PCA, UMAP, t-SNE, or PACMAP.
Cell Type Identification
✅ Supported
scRNA-seq
Match cell clusters to reference annotations from public atlases. uses marker gene scoring and optional references.
Discovery Engine
✅ Supported
All
Leveraging the power of Mithrl's Lattice Knowledge Graph to auto-surface known & predicted associations, drug links, and co-expression via the knowledge inference engine.
WGS/WES Analysis
🔜 Coming Soon
Genomic
Detect mutations and structural variants; link to transcriptomic impact
DNA Methylation (Bulk + sc)
🔜 Coming Soon
Epigenomic
Identify differentially methylated regions and correlate with gene activity
Proteomics Integration
🔜 Coming Soon
Proteomic
Connect transcript expression to protein-level data and changes
Metabolomics Integration
🔜 Coming Soon
Metabolomic
Map transcriptomic shifts to metabolic pathways and readouts
Multi-Omics Cohort Analysis
🔜 Coming Soon
Multi-omics
Analyze across multiple omics (e.g., RNA, DNA, protein) into unified analysis
Lead Optimization AI
🔜 Coming Soon
Downstream
Suggest lead molecules based on gene signature, pathway response, and SAR overlays
High-Throughput Screening AI
🔜 Coming Soon
Downstream
Interpret large HTS datasets using AI-guided dimensionality reduction, target filtering, and phenotypic enrichment
IND Support AI
🔜 Coming Soon
Preclinical
Identify toxicogenomic signatures, validate biomarkers across species, and generate IND-ready transcriptomic justifications
Clinical Trial Analysis AI
🔜 Coming Soon
Clinical
Stratify trial arms, match molecular subtypes to response groups, identify responder biomarkers, and generate trial decision support summaries
Still have questions? We have answers. Contact us at support@mithrl.com
Last updated
Was this helpful?